VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ELVN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ELVNEnliven Therapeutics, Inc.
$49.43$3.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksELVNQuarterly Balance Sheet

Enliven Therapeutics, Inc. (ELVN) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Enliven Therapeutics, Inc. (ELVN) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

ELVN Balance Sheet

Quarterly statement

ELVN Balance Sheet

Enliven Therapeutics, Inc. (ELVN) balance sheet — 9-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Total Current Assets894.76M907.34M463.14M474.88M482.68M495.62M294.32M318.13M297M318.13M337.2M266.15M268.61M283.18M298M77.75M88.23M64.26M78.53M110.67M
Cash & Short-Term Investments884.35M895.15M452.4M462.62M477.56M490.5M289.56M313.44M291.83M312.39M320.5M253.15M263.48M277.87M292.1M75.54M86.16M60.34M72.9M110.02M
Cash Only151.67M135.5M132.18M98.9M101.73M119.44M101.7M124.12M100.62M96.87M149.16M100.14M73.85M125.72M292.1M75.54M86.16M30.43M36.48M110.02M
Short-Term Investments732.68M759.65M320.22M363.73M375.83M371.07M187.85M189.32M191.21M215.52M171.34M153.01M189.63M152.15M00029.91M36.42M0
Accounts Receivable00000000000000000000
Days Sales Outstanding--------------------
Inventory00000000000000000000
Days Inventory Outstanding--------------------
Other Current Assets10.4M010.74M12.26M5.12M04.76M4.69M54K5.74M10.05M10.05M005.9M2.22M03.92M5.63M0
Total Non-Current Assets2.47M2.88M1.72M1.29M8.19M8.27M8.25M7.63M8.43M8.92M5.58M5.72M5.43M5.33M4.86M5.54M2.57M410K3.07M2.66M
Property, Plant & Equipment1.51M1.64M310K417K874K1.03M1.05M458K630K791K924K1.06M1.2M1.34M1.4M1.52M1.55M235K2.9M954K
Fixed Asset Turnover--------------------
Goodwill00000000000000000000
Intangible Assets00000000000000000000
Long-Term Investments0000000000000054K54K0175K175K0
Other Non-Current Assets962K1.24M1.41M873K7.32M7.24M7.2M7.17M7.8M8.13M4.65M4.65M4.23M3.98M3.4M3.98M1.01M001.71M
Total Assets897.23M910.22M464.85M476.17M490.88M503.89M302.57M325.76M305.43M327.04M342.78M271.87M274.04M288.5M302.87M83.3M90.8M64.67M81.6M113.33M
Asset Turnover--------------------
Asset Growth %82.78%80.64%53.63%46.17%60.72%54.07%-11.73%19.82%11.45%13.36%13.18%226.38%201.82%346.14%271.15%-26.5%-15.17%-10.77%-0.1%24.75%
Total Current Liabilities19.47M14.16M11.49M16.57M14.65M15.21M13.97M15.91M17.03M22.11M25.03M25.89M12.08M9.15M10.94M9.71M8.33M3.3M7.22M5.75M
Accounts Payable2.73M371K1.64M2.16M1.43M2.35M1.56M1.34M1.02M1.08M2.73M532K1.49M2.84M5.86M3.44M2.99M1.14M1.88M2.52M
Days Payables Outstanding---3.59K----------------
Short-Term Debt0597K000000000000000445K508K0
Deferred Revenue (Current)0000000000000005.51M0000
Other Current Liabilities174K10.16M2.37M4.65M4.04M63K2.16M4.81M216K11.57M10.45M10.36M368K692K3.72M320K1.08M1.05M3.7M233K
Current Ratio45.95x64.07x40.32x28.66x32.95x32.58x21.06x19.99x17.44x14.39x13.47x10.28x22.24x30.96x27.23x8.00x10.59x19.46x10.87x19.24x
Quick Ratio45.95x64.07x40.32x28.66x32.95x32.58x21.06x19.99x17.44x14.39x13.47x10.28x22.24x30.96x27.23x8.00x10.59x19.46x10.87x19.24x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities805K913K0108K103K204K302K006K34K67K214K360K508K150.41M810K1.58M1.97M714K
Long-Term Debt0913K000000000000000000
Capital Lease Obligations805K0000204K0000000000001.97M0
Deferred Tax Liabilities000108K0000000000000000
Other Non-Current Liabilities0000103K0302K006K34K67K214K360K508K150.41M810K1.58M0714K
Total Liabilities20.28M15.07M11.49M16.68M14.75M15.41M14.27M15.91M17.03M22.11M25.07M25.96M12.29M9.51M11.45M160.12M9.14M3.3M9.19M6.47M
Total Debt1.31M1.51M302K399K387K580K365K085K169K252K335K332K329K326K323K320K445K2.48M159K
Net Debt-150.35M-134M-131.88M-98.5M-101.34M-118.86M-101.34M-124.12M-100.54M-96.7M-148.91M-99.81M-73.52M-125.39M-291.78M-75.21M-85.84M-29.99M-34.01M-109.86M
Debt / Equity0.00x0.00x0.00x0.00x0.00x0.00x0.00x-0.00x0.00x0.00x0.00x0.00x0.00x0.00x-0.00x0.01x0.03x0.00x
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage--------------------
Total Equity876.95M895.15M453.37M459.6M476.12M488.47M288.3M309.85M288.4M304.93M317.71M245.91M261.75M278.99M291.42M-76.83M81.65M61.36M72.41M106.86M
Equity Growth %84.19%83.25%57.26%48.33%65.09%60.19%-9.26%26%10.18%9.3%9.02%420.09%220.57%354.65%302.44%-171.89%-17.83%-5.55%-4.21%26.56%
Book Value per Share11.2513.537.228.117.679.375.766.215.986.347.565.986.386.8115.74-11.6912.429.3411.0216.26
Total Shareholders' Equity876.95M895.15M453.37M459.6M476.12M488.47M288.3M309.85M288.4M304.93M317.71M245.91M261.75M278.99M291.42M-76.83M81.65M61.36M72.41M106.86M
Common Stock74K73K61K59K59K59K49K49K47K47K47K41K41K41K41K1K1K27K27K1K
Retained Earnings-430.98M-403.28M-370.79M-347.17M-317.5M-297.35M-272.02M-243.47M-220.29M-197.14M-177.19M-154.45M-135.08M-114.31M-97.59M-82.86M-73.31M-173.59M-162.14M-45.2M
Treasury Stock00000000000000000000
Accumulated OCI-3.51M-1.91M-382K334K221K-177K-16K55K242K-139K-53K141K-147K-111K0-149.75K0-35K-51K0
Minority Interest00000000000000000000